Literature DB >> 2308836

Nuclear factor-I and activator protein-2 bind in a mutually exclusive way to overlapping promoter sequences and trans-activate the human growth hormone gene.

S J Courtois1, D A Lafontaine, F P Lemaigre, S M Durviaux, G G Rousseau.   

Abstract

Transcription of the human growth hormone (hGH) gene and its regulation are controlled by trans-acting factors that bind to hGH gene promoter sequences. Several DNase I footprints have been described within 500 bp of this promoter, one of which (-289 to -267) has not yet been ascribed to a defined factor. By DNase I footprinting, gel mobility shift, and methylation interference assays with extracts from HeLa cells and GH-producing pituitary tumor (GC) cells, we show that this factor belongs to the NF-I family. When NF-I was competed out of the cell extracts, the trans-acting factor AP-2 bound to the same site as NF-I. AP-2 was present not only in HeLa cells, but also in GC cells albeit at a much lower concentration. Consistent with the mutually exclusive binding of NF-I and AP-2, their methylation interference patterns included four guanine residues that were crucial for binding of both NF-I and AP-2. Cell-free transcription from the hGH gene promoter showed that these two factors can transactivate this gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2308836      PMCID: PMC330203          DOI: 10.1093/nar/18.1.57

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  31 in total

1.  Purification of nuclear factor I by DNA recognition site affinity chromatography.

Authors:  P J Rosenfeld; T J Kelly
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

2.  Binding of the human glucocorticoid receptor to defined regions in the human growth hormone and placental lactogen genes.

Authors:  P H Eliard; M J Marchand; G G Rousseau; P Formstecher; M Mathy-Hartert; A Belayew; J A Martial
Journal:  DNA       Date:  1985-12

Review 3.  Transcriptional selectivity of viral genes in mammalian cells.

Authors:  S McKnight; R Tjian
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

Review 4.  Structure and evolution of the growth hormone gene family.

Authors:  W L Miller; N L Eberhardt
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

5.  An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter.

Authors:  R W Carthew; L A Chodosh; P A Sharp
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

6.  The first intron of the human growth hormone gene contains a binding site for glucocorticoid receptor.

Authors:  D D Moore; A R Marks; D I Buckley; G Kapler; F Payvar; H M Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

7.  The TGGCA protein binds to the MMTV-LTR, the adenovirus origin of replication, and the BK virus enhancer.

Authors:  J Nowock; U Borgmeyer; A W Püschel; R A Rupp; A E Sippel
Journal:  Nucleic Acids Res       Date:  1985-03-25       Impact factor: 16.971

8.  Purification of growth hormone-specific transcription factor GHF-1 containing homeobox.

Authors:  J L Castrillo; M Bodner; M Karin
Journal:  Science       Date:  1989-02-10       Impact factor: 47.728

9.  Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene.

Authors:  N Hynes; A J van Ooyen; N Kennedy; P Herrlich; H Ponta; B Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Transcription factors AP-3 and AP-2 interact with the SV40 enhancer in a mutually exclusive manner.

Authors:  F Mercurio; M Karin
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  18 in total

1.  Prolactin-regulated pim-1 transcription: identification of critical promoter elements and Akt signaling.

Authors:  Nithya Krishnan; Huiqi Pan; Donna J Buckley; Arthur Buckley
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

2.  Transcription factors nuclear factor I and Sp1 interact with the murine collagen alpha 1 (I) promoter.

Authors:  M C Nehls; R A Rippe; L Veloz; D A Brenner
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Compilation of vertebrate-encoded transcription factors.

Authors:  S Faisst; S Meyer
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

4.  Identification of regulatory sequences and protein-binding sites in the liver-type promoter of a gene encoding 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Authors:  F P Lemaigre; S M Durviaux; G G Rousseau
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

5.  On the role of AP2 in epithelial-specific gene expression.

Authors:  T Magnaldo; R G Vidal; M Ohtsuki; I M Freedberg; M Blumenberg
Journal:  Gene Expr       Date:  1993

6.  Two regions within the DNA binding domain of nuclear factor I interact with DNA and stimulate adenovirus DNA replication independently.

Authors:  J Dekker; J A van Oosterhout; P C van der Vliet
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

7.  CDF-1-mediated repression of cell cycle genes targets a specific subset of transactivators.

Authors:  J Zwicker; F C Lucibello; V Jérôme; S Brüsselbach; R Müller
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

8.  Transcription factor AP-2 regulates human apolipoprotein E gene expression in astrocytoma cells.

Authors:  M A García; J Vázquez; C Giménez; F Valdivieso; F Zafra
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

Review 9.  Roles of lumican and keratocan on corneal transparency.

Authors:  Winston W-Y Kao; Chia-Yang Liu
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

10.  In vivo stimulation of a chimeric promoter by binding sites for nuclear factor I.

Authors:  J J Knox; P J Rebstein; A Manoukian; R M Gronostajski
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.